AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
IVAX Receives FDA Approvable Letter for Albuterol HFA in Breath-Activated Inhaler.
MIAMI -- IVAX Corporation (AMEX:IVX)(LSE:IVX.L) announced today that it has received an approvable letter from the United States Food and Drug Administration (FDA) for its New Drug Application (NDA) for albuterol sulfate using non-ozone-depleting, CFC-free propellant in IVAX' patented breath-activated aerosol inhaler.
Albuterol, a beta-agonist bronchodilator, is the primary rescue medicine for the relief of asthma symptoms. Over 90% of the more than 50 million albuterol inhalers sold in the U.S. last year contained chlorofluorocarbon (CFC) propellants, which are expected to be eventually removed from the market due to concern about ozone depletion. On June 16, 2004, the FDA issued a proposed rule to remove the essential-use designation for CFC albuterol inhalers. IVAX' formulation of albuterol uses hydrofluoroalkane (HFA), a non-ozone-depleting, CFC-free propellant.
IVAX' patented breath-activated aerosol inhaler, marketed in Europe under the name Easi-Breathe(R), is the best-selling breath-activated aerosol inhaler in the United Kingdom, the world's second largest asthma market. This inhaler eliminates the need to coordinate the manual release of the medicine with inhalation of the medicine, which is required by standard metered dose inhalers. Such coordination can be difficult and sub-optimal synchronization can result in the medicine not reaching the lungs.
Upon receipt of final FDA approval, IVAX will market this product through its wholly owned subsidiary, IVAX Laboratories, Inc. IVAX has previously received an approvable letter from the FDA on a separate NDA for an HFA formulation of albuterol in a standard metered dose inhaler.
IVAX Corporation, headquartered in Miami, Florida, discovers, develops, manufactures, and markets branded and brand equivalent (generic) pharmaceuticals and veterinary products in the U.S. and internationally.
Copies of this and other news releases may be obtained free of charge from IVAX' website at ...
- FDA issues approvable letter for Albuterol HFA in breath-activated inhaler.
- Newspaper article from: Obesity, Fitness & Wellness Week July 31, 2004 700+ words
...amp; NewsRx.net) -- IVAX Corporation (IVX) has received an approvable letter from the U.S. Food and...wholly owned subsidiary, IVAX Laboratories, Inc. IVAX has previously received an approvable letter from the FDA on a separate...
- Teva Receives Follow-up Approvable Letter from FDA Regarding Agilect(R).
- Press release article from: Business Wire August 5, 2005 700+ words
...whether and when the proposed acquisition with Ivax Corporation will be consummated and the terms...of the financing utilized by Teva for the Ivax acquisition, Teva's ability to rapidly integrate Ivax's operations and achieve expected synergies...
- Neurocrine Receives Approvable Letter for Indiplon Capsules with Additional...
- Press release article from: PR Newswire December 13, 2007 700+ words
...10 mg capsules were approvable (2006 Approvable Letter). The 2006 Approvable Letter requested that the company reanalyze...middle of the night dosing. The 2006 Approvable Letter also requested reexamination of the safety...
- Third Time's Not A Charm Encysive Tanks On Third PAH Approvable Letter For...
- Magazine article from: BIOWORLD Today Morrison, Trista June 19, 2007 700+ words
...based company received its third approvable letter for Thelin (sitaxsentan sodium...of Thelin, but received its first approvable letter in March 2006. Although the letter...submitted its complete response to the approvable letter. The response was based on existing...
- Labopharm Receives Second Approvable Letter from FDA for Once-Daily Tramadol.
- Press release article from: PR Newswire May 31, 2007 700+ words
...announced that it has received a second approvable letter from the U.S. Food and Drug Administration...formulation of tramadol. In the second approvable letter (dated May 30, 2007), the FDA...assessment of our response to its initial approvable letter," said James R. Howard-Tripp...
- Labopharm Falls 50 Percent On Second FDA Approvable Letter.
- Magazine article from: BIOWORLD Today Shrine, Jim June 4, 2007 700+ words
...The FDA sent Labopharm a second approvable letter on its new drug application, this...to close at $3.07. The first approvable letter from the FDA came in late September...language when it received the first approvable letter. (See BioWorld Today, Oct. 2...
- FDA Issues Approvable Letter for Expanded Use of Vivelle-Dot and Addition of...
- Press release article from: Business Wire December 11, 2001 700+ words
...Novartis Pharmaceuticals Corporation an approvable letter relating to the expanded use of Vivelle...The expanded use addressed in the approvable letter includes the prevention of postmenopausal...075 and 0.1 mg/day). The approvable letter relates to the addition of a new...
- FDA Wants More Trials Neurocrine Falls 49% On Second Approvable Letter For...
- Magazine article from: BIOWORLD Today Morrison, Trista December 14, 2007 700+ words
...The FDA delivered a second approvable letter for Neurocrine Biosciences...delivered an unexpected approvable letter for the 5-mg and 10...release capsules and a non-approvable letter for the 15-mg modified...